Elizabeth A. Stier

Why Gynecologists Must Become Anal Cancer–Prevention Specialists

Nadi Kaonga, Mary Grace Tadros, Patricia P. Jeudin, Elizabeth A. Stier et autres

Anal cancer incidence is rising in the United States, with the fastest increases among older women, a population not traditionally considered high risk. Despite its shared human papillomavirus etiology with cervical cancer, clinical capacity for anal cancer screening and prevention remains limited, …

us (code pays fourni par la source)

Screening for Anal Cancer Among Men Who Have Sex With Men With HIV: Benefits, Harms, and Cost-Effectiveness Analyses

Ashish Ambadas Deshmukh, Haluk Damgacioglu, Keith Magnus Sigel, Joel Michael Palefsky et autres

BACKGROUND: Following the success of the ANCHOR (Anal Cancer-HSIL Outcomes Research) trial, the U.S. Department of Health and Human Services recommends anal cancer screening for high-risk persons, particularly men who have sex with men (MSM) with HIV. OBJECTIVE: To quantify the cost-effectiveness …

us, pr, fr (code pays fourni par la source)

Reply to comments on: “International Anal Neoplasia Society's consensus guidelines for anal cancer screening”

Elizabeth A. Stier, Megan A. Clarke, Ashish Ambadas Deshmukh, Nicolas Wentzensen et autres

us, au, it, ar, gb (code pays fourni par la source)

Health-Related Quality of Life for Persons Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (AMC-A01)

Thomas M. Atkinson, Madhu Mazumdar, Grace Van Hyfte, Jeannette Y. Lee et autres

PURPOSE The Anal Cancer/High-grade squamous intraepithelial lesions Outcomes Research (ANCHOR) trial demonstrated that treating precancerous anal HSIL reduces the incidence of anal cancer by 57% in people with HIV. It remains unclear how HSIL treatment or monitoring without treatment affects patient-reported health-related …

us (code pays fourni par la source)

A novel method for semi-quantitative detection of HPV16 and HPV18 mRNA with a low-cost, open-source fluorimeter

Kathryn A. Kundrod, Mary E. Natoli, Chelsey A. Smith, Jackson B. Coole et autres

Despite global calls to eliminate cervical cancer, rates of cervical cancer incidence and mortality remain high in resource-limited settings, where it is challenging to implement and sustain screening, diagnosis, and treatment programs. The presence of high-risk HPV mRNA in cervical cells is …

us (code pays fourni par la source)

Prevalence of anal high‐risk human papillomavirus ( HR ‐ HPV) types in people living with HIV and a history of cancer

Salim Abraham Barquet-Muñoz, Roxana A. López‐Morales, Elizabeth A. Stier, Emmanuel Mejorada‐Pulido et autres

This study aimed to describe the prevalence of high-risk human papillomavirus (HR-HPV) types in the anal canal in a cohort of people living with HIV (PLWHIV) with a history of malignancy. SETTING: Referral tertiary care hospital for adult patients with cancer. METHODS: …

mx, us (code pays fourni par la source)

EPR24-116: Improving Anal Cancer Screening: A Comparative Analysis of High-Risk Human Papillomavirus Tests, Alone or in Combination With Anal Cytology Assays, to Predict High-Grade Squamous Intraepithelial Lesions

Derek W. Ren, Hil Hsu, Jenny K. Brook, Gypsyamber DʼSouza et autres

"EPR24-116: Improving Anal Cancer Screening: A Comparative Analysis of High-Risk Human Papillomavirus Tests, Alone or in Combination With Anal Cytology Assays, to Predict High-Grade Squamous Intraepithelial Lesions" published on 05 Apr 2024 by National Comprehensive Cancer Network.

us (code pays fourni par la source)

International Anal Neoplasia Society's consensus guidelines for anal cancer screening

Elizabeth A. Stier, Megan A. Clarke, Ashish Ambadas Deshmukh, Nicolas Wentzensen et autres

The International Anal Neoplasia Society (IANS) developed consensus guidelines to inform anal cancer screening use among various high-risk groups. Anal cancer incidence estimates by age among risk groups provided the basis to identify risk thresholds to recommend screening. Guided by risk thresholds, …

us, au, it, ar, fr, gb (code pays fourni par la source)

Two-Year Incidence and Cumulative Risk and Predictors of Anal High-Grade Squamous Intraepithelial Lesions (Anal Precancer) Among Women With Human Immunodeficiency Virus

Elizabeth A. Stier, Mayuri Jain, Himanshu N. Joshi, Teresa M. Darragh et autres

BACKGROUND: Detection and treatment of anal histologic high-grade squamous intraepithelial lesions (hHSIL) prevents anal cancer. However, anal hHSIL incidence among women with human immunodeficiency virus (HIV, WHIV) remains unknown. Performance of anal high-risk human papillomavirus ([hr]HPV), anal cytology (anal-cyt), and both for …

us, pr (code pays fourni par la source)

Truth or DARE (Digital Anal Rectal Examination): Gynecologist Viewpoints on Anal Cancer Screening

Laura M. Gaydos, Danielle M. Blemur, Tahira L Perry, Elizabeth A. Stier et autres

METHODS: The authors conducted a survey for practicing gynecologists recruited through academic institutions, professional societies, and professional groups on social media resulting in 196 respondents. The survey, fielded between January and June 2022, included questions on knowledge, attitudes, training, and practices regarding …

us (code pays fourni par la source)

Sexually Transmitted Human Papillomavirus

Rosalyn E. Plotzker, Akanksha Vaidya, Utsav Pokharel, Elizabeth A. Stier

us (code pays fourni par la source)

Construct validity and responsiveness of a health-related symptom index for persons either treated or monitored for anal high-grade squamous intraepithelial lesions (HSIL): AMC-A01/-A03

Thomas M. Atkinson, Shelly Lensing, Jeannette Y. Lee, Di Chang et autres

us (code pays fourni par la source)